BLOO7 schreef op 8 maart 2019 11:11:
[...]
www.gilead.com/news-and-press/press-r...John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of Research & Development, will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami on Tuesday, March 12 at 10:45 a.m. Eastern Time.
www.beursduivel.be/Beursnieuws/297849...Galapagos meldt "indrukwekkende" testresultaten
"We blijven grote mogelijkheden zien om met filgotinib een reeks van ontstekingsziekten te behandelen," zei John McHutchison, MD, Chief Scientific Officer, Head of Research and Development, Gilead.
DE filgotinib-kenner bij uitstek van Gilead is in ieder geval present!